Aibotics, Inc. (AIBT)
0.0005
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Aibotics Debt to Equity Ratio : -0.2804 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2804 |
| March 31, 2026 | -0.3173 |
| December 31, 2025 | -0.324 |
| September 30, 2025 | -0.381 |
| June 30, 2025 | -0.3605 |
| March 31, 2025 | -0.3297 |
| December 31, 2024 | -0.3726 |
| September 30, 2024 | -0.3766 |
| June 30, 2024 | -0.4325 |
| March 31, 2024 | -0.5154 |
| December 31, 2023 | -0.5377 |
| September 30, 2023 | -0.5996 |
| June 30, 2023 | -0.6495 |
| March 31, 2023 | -0.6621 |
| December 31, 2022 | -0.7351 |
| September 30, 2022 | -1.273 |
| June 30, 2022 | -2.619 |
| Date | Value |
|---|---|
| March 31, 2022 | 5.440 |
| December 31, 2021 | 14.40 |
| September 30, 2021 | 2.779 |
| June 30, 2021 | -4.738 |
| March 31, 2021 | -5.102 |
| December 31, 2020 | -7.716 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| September 30, 2019 | 0.0209 |
| June 30, 2019 | 0.0231 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| CS Diagnostics Corp. | 0.00 |
| GeneDx Holdings Corp. | 0.6855 |
| Ayujoy Herbals Ltd. | -- |
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.5496M |
| Total Liabilities (Quarterly) | 5.152M |
| Shareholders Equity (Quarterly) | -4.602M |
| Current Ratio | 0.0535 |
| Net Debt Paydown Yield | -1.17% |